Literature DB >> 1996105

An "attenuator domain" is sandwiched by two distinct transactivation domains in the transcription factor C/EBP.

D Q Pei1, C H Shih.   

Abstract

C/EBP is a rat liver DNA-binding protein which can act as a transcription factor. Its N-terminal portion contains three distinct domains. The first domain (amino acids 1 to 107) appears to be a highly potent transactivator. The second domain (amino acids 107 to 170) does not appear to exhibit either activation or repression activity. This domain is defined as an "attenuator domain" because its presence under four different sequence contexts reproducibly decreases the effect of transactivation of C/EBP. The third domain (amino acids 171 to 245) is a relatively weaker transactivator with a striking proline-rich motif. Deletional analysis of this third domain has shown that a 45-amino-acid region is sufficient for transactivation. This region (amino acids 171 to 215) contains 12 proline, 6 histidine, and mainly hydrophobic or noncharged amino acids. Further mutational analysis of a highly conserved proline-octamer region within this domain indicates that a specific proline content is not crucial for transactivation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1996105      PMCID: PMC369429          DOI: 10.1128/mcb.11.3.1480-1487.1991

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  34 in total

1.  cis rescue of a mutated reverse transcriptase gene of human hepatitis B virus by creation of an internal ATG.

Authors:  S Roychoudhury; C Shih
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

2.  Transcriptional activation and repression by cellular DNA-binding protein C/EBP.

Authors:  D Q Pei; C H Shih
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

3.  Homologous recognition of a promoter domain common to the MSV LTR and the HSV tk gene.

Authors:  B J Graves; P F Johnson; S L McKnight
Journal:  Cell       Date:  1986-02-28       Impact factor: 41.582

4.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

5.  CCAAT/enhancer binding protein activates the promoter of the serum albumin gene in cultured hepatoma cells.

Authors:  A D Friedman; W H Landschulz; S L McKnight
Journal:  Genes Dev       Date:  1989-09       Impact factor: 11.361

6.  Functional dissection of a eukaryotic transcriptional activator protein, GCN4 of yeast.

Authors:  I A Hope; K Struhl
Journal:  Cell       Date:  1986-09-12       Impact factor: 41.582

7.  Disruption of a C/EBP binding site in the factor IX promoter is associated with haemophilia B.

Authors:  M Crossley; G G Brownlee
Journal:  Nature       Date:  1990-05-31       Impact factor: 49.962

8.  Multiple liver-specific factors bind to the hepatitis B virus core/pregenomic promoter: trans-activation and repression by CCAAT/enhancer binding protein.

Authors:  M López-Cabrera; J Letovsky; K Q Hu; A Siddiqui
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

9.  Tissue-specific in vitro transcription from the mouse albumin promoter.

Authors:  K Gorski; M Carneiro; U Schibler
Journal:  Cell       Date:  1986-12-05       Impact factor: 41.582

10.  A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family.

Authors:  S Akira; H Isshiki; T Sugita; O Tanabe; S Kinoshita; Y Nishio; T Nakajima; T Hirano; T Kishimoto
Journal:  EMBO J       Date:  1990-06       Impact factor: 11.598

View more
  28 in total

1.  A common motif within the negative regulatory regions of multiple factors inhibits their transcriptional synergy.

Authors:  J A Iñiguez-Lluhí; D Pearce
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

2.  Definition of the transcriptional activation domain of recombinant 43-kilodalton USF.

Authors:  B J Kirschbaum; P Pognonec; R G Roeder
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

3.  c/CEPB, a chicken transcription factor of the leucine-zipper C/EBP family [corrected].

Authors:  C F Calkhoven; G Ab; J Wijnholds
Journal:  Nucleic Acids Res       Date:  1992-08-11       Impact factor: 16.971

Review 4.  CCAAT/enhancer-binding proteins and the pathogenesis of retrovirus infection.

Authors:  Yujie Liu; Michael R Nonnemacher; Brian Wigdahl
Journal:  Future Microbiol       Date:  2009-04       Impact factor: 3.165

5.  Physical dissection of the CCAAT/enhancer-binding protein alpha in regulating the mouse amelogenin gene.

Authors:  Yucheng Xu; Yan Larry Zhou; Robin L Erickson; Ormond A Macdougald; Malcolm L Snead
Journal:  Biochem Biophys Res Commun       Date:  2007-01-02       Impact factor: 3.575

6.  Hepatocyte-like cells transdifferentiated from a pancreatic origin can support replication of hepatitis B virus.

Authors:  Robert Yung-Liang Wang; Chia-Ning Shen; Min-Hui Lin; David Tosh; Chiaho Shih
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

7.  Evidence for posttranscriptional regulation of C/EBPalpha and C/EBPbeta isoform expression during the lipopolysaccharide-mediated acute-phase response.

Authors:  M R An; C C Hsieh; P D Reisner; J P Rabek; S G Scott; D T Kuninger; J Papaconstantinou
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

Review 8.  CCAAT/enhancer-binding proteins: structure, function and regulation.

Authors:  Dipak P Ramji; Pelagia Foka
Journal:  Biochem J       Date:  2002-08-01       Impact factor: 3.857

9.  ADR1c mutations enhance the ability of ADR1 to activate transcription by a mechanism that is independent of effects on cyclic AMP-dependent protein kinase phosphorylation of Ser-230.

Authors:  C L Denis; S C Fontaine; D Chase; B E Kemp; L T Bemis
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

10.  A complex interplay of positive and negative elements is responsible for the different transcriptional activity of liver NF1 variants.

Authors:  P Monaci; M Nuzzo; S Stampfli; D Tollervey; V De Simone; A Nicosia
Journal:  Mol Biol Rep       Date:  1995       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.